Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.

Comparing Walgreens and Taro's Gross Profit Trends (2014-2024)

__timestampTaro Pharmaceutical Industries Ltd.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 201458000600021569000000
Thursday, January 1, 201567658500026753000000
Friday, January 1, 201677896600029874000000
Sunday, January 1, 201767125100029162000000
Monday, January 1, 201846350800030792000000
Tuesday, January 1, 201944572400028159000000
Wednesday, January 1, 202039972500026077000000
Friday, January 1, 202129665600028067000000
Saturday, January 1, 202229312200028266000000
Sunday, January 1, 202326832300027072000000
Monday, January 1, 202430497900026524000000
Loading chart...

Unleashing the power of data

Gross Profit Trends: Walgreens Boots Alliance vs. Taro Pharmaceutical

In the ever-evolving pharmaceutical landscape, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Walgreens Boots Alliance, Inc. and Taro Pharmaceutical Industries Ltd. from 2014 to 2024. Walgreens, a retail giant, consistently outperformed Taro, a niche pharmaceutical player, with gross profits peaking at approximately $30.8 billion in 2018. In contrast, Taro's highest gross profit was around $779 million in 2016. Over the decade, Walgreens maintained a robust average gross profit of $27.5 billion, while Taro averaged $471 million. Notably, Walgreens experienced a 43% increase in gross profit from 2014 to 2018, while Taro saw a 34% decline from 2016 to 2023. These trends highlight the contrasting scales and market dynamics of these companies, offering valuable insights for investors and industry analysts.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025